ENZOMAC

Main information

  • Trade name:
  • ENZOMAC 10 F.
  • Dosage:
  • 96,180,200;MG
  • Pharmaceutical form:
  • F.
  • Composition:
  • 10
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ENZOMAC 10 F.
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

18-12-2018

EU/3/18/2113 (MUCPharm Pty Ltd)

EU/3/18/2113 (MUCPharm Pty Ltd)

EU/3/18/2113 (Active substance: Bromelain) - Orphan designation - Commission Decision (2018)9028 of Tue, 18 Dec 2018 European Medicines Agency (EMA) procedure number: EMA/OD/144/18

Europe -DG Health and Food Safety

2-10-2018

NexoBrid (MediWound Germany GmbH)

NexoBrid (MediWound Germany GmbH)

NexoBrid (Active substance: Concentrate of proteolytic enzymes enriched in bromelain) - PSUSA - Modification - Commission Decision (2018)6460 of Tue, 02 Oct 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/10028/201712

Europe -DG Health and Food Safety